Developments in the immunophenotypic analysis of haematological malignancies

Abstract Immunophenotyping is the method by which antibodies are used to detect cellular antigens in clinical samples. Although the major role is in the diagnosis and classification of haematological malignancies, applications have expanded over the past decade. Immunophenotyping is now used extensi...

Full description

Saved in:
Bibliographic Details
Published inBlood reviews Vol. 27; no. 4; pp. 193 - 207
Main Authors Heel, Kathy, Tabone, Tania, Röhrig, Kimberley J, Maslen, Phillip G, Meehan, Katie, Grimwade, Lizz F, Erber, Wendy N
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.07.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Immunophenotyping is the method by which antibodies are used to detect cellular antigens in clinical samples. Although the major role is in the diagnosis and classification of haematological malignancies, applications have expanded over the past decade. Immunophenotyping is now used extensively for disease staging and monitoring, to detect surrogate markers of genetic aberrations, to identify potential immuno-therapeutic targets and to aid prognostic prediction. This expansion in applications has resulted from developments in antibodies, methodology, automation and data handling. In this review we describe recent advances in both the technology and applications for the analysis of haematological malignancies. We highlight the importance of the expanding repertoire of testing capability for diagnostic, prognostic and therapeutic applications. The impact and significance of immunophenotyping in the assessment of haematological neoplasms are evident.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0268-960X
1532-1681
DOI:10.1016/j.blre.2013.06.005